BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Xie Q, Xuan JW, Tang H, Ye XG, Xu P, Lee IH, Hu SL. Hepatitis C virus cure with direct acting antivirals: Clinical, economic, societal and patient value for China. World J Hepatol 2019; 11(5): 421-441 [PMID: 31183003 DOI: 10.4254/wjh.v11.i5.421]
URL: https://www.wjgnet.com/1948-5182/full/v11/i5/421.htm
Number Citing Articles
Rong Chen, Jun Chen, Qi Tang, Zhihao Meng, Ling Luo, Wei Zhang, Aihua Deng, Lukun Zhang, Jiangrong Wang, Tangkai Qi, Renfang Zhang, Yinzhong Shen, Li Liu, Corky Steinhart, Hongzhou Lu. Use of comedications and potential drug-drug interactions in people living with HIV in ChinaJournal of Infection and Chemotherapy 2020; 26(7): 722 doi: 10.1016/j.jiac.2020.04.003
AhmedSaqer Alotaibi, Nour Shamas, UmairUddin Ansari, FaisalM Sanai, Ali Alshahrani, AhmedIbrahim Fathelrahman, MohammedAli Aseeri. Impact of drug use policy on the appropriate use of direct acting antiviral agents for Hepatitis C in Saudi ArabiaJournal of Pharmacy And Bioallied Sciences 2021; 13(3): 317 doi: 10.4103/jpbs.jpbs_166_21
V.I. Trykhlib. Хронический вирусный гепатит С. Эффективность противовирусной терапии. Данные методических рекомендаций ВОЗ (обзор литературы)ACTUAL INFECTOLOGY 2021; 8(1): 1 doi: 10.22141/2312-413x.8.1.2020.196165
Yuting He, Yichong Wang, Xuefang Chen, Hao Huang, Jiankai Deng, Peisong Chen, Huang Bin. Performance evaluation of the DAAN HCV assay for quantification of hepatitis C virus RNA and its comparison with COBAS AmpliPrep/COBAS TaqMan HCV Quantitative Test, v2.0Journal of Clinical Laboratory Analysis 2020; 34(7) doi: 10.1002/jcla.23280
Liangying Gan, Dongyu Wang, Brian Bieber, Keith McCullough, Michel Jadoul, Ronald L. Pisoni, Fanfan Hou, Xinling Liang, Zhaohui Ni, Xiaonong Chen, Yuqing Chen, Li Zuo. Hepatitis C Prevalence, Incidence, and Treatment in Chinese Hemodialysis Patients: Results From the Dialysis Outcomes and Practice Patterns Study-China (2019–21)Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.910840
Maan T. Khayat, Abdelsattar M. Omar, Mahmoud A. Elfaky, Yosra A. Muhammad, Elaf A. Felemban, Khalid M. El-Say, Moustafa E. El-Araby, Jin Xie. Reexamining Povarov Reaction’s Scope and Limitation in the Generation of HCV-NS4A PeptidomimeticsHeteroatom Chemistry 2022; 2022: 1 doi: 10.1155/2022/8181543
Jinyu Liu, Yu Zhang, Bin Wu, Sen Wang, David Bin-Chia Wu, Ruxu You. Cost-Effectiveness of Testing for NS5A Resistance to Optimize Treatment of Elbasvir/Grazoprevir for Chronic Hepatitis C in ChinaFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.717504
Halinuer Shadekejiang, Jiefu Zhu, Xiongfei Wu. Transplant of Kidneys From Hepatitis C Virus-Positive Donors To Hepatitis C Virus-Negative Recipients: A Retrospective Study and Systematic ReviewExperimental and Clinical Transplantation 2022; 20(12): 1076 doi: 10.6002/ect.2022.0315
Mingyang Li, Hui Zhuang, Lai Wei. How would China achieve WHO’s target of eliminating HCV by 2030?Expert Review of Anti-infective Therapy 2019; 17(10): 763 doi: 10.1080/14787210.2019.1675509